FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Memantine 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) 60 tablet 6 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) 60 tablet 6 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 250mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 250mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 500mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 500mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 50mg capsules (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 50mg capsules (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 150mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 150mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 100mg capsules (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 100mg capsules (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Anagrelide 500microgram capsules (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Anagrelide 500microgram capsules (Sandoz Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) 21 tablet 3 x 7 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) 21 tablet 3 x 7 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 20 tablet 2 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 20 tablet 2 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) 6 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) 6 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 250mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 250mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 500mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 500mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 50mg capsules (Bristol Laboratories Ltd) 84 capsule 6 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 50mg capsules (Bristol Laboratories Ltd) 84 capsule 6 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 325 of 342 Next End


    This concept is not in any reference sets

    Back to Start